Hyloris Announces Major Commercial Partnership in the U.S. for Maxigesic® IV

by NASDAQ Market News April 28, 2021

NASDAQ Market News
Click here to email author

Sanofi continued its growth trajectory. Strong increase in Q1 2021 business EPS(1) at CER

US FDA Advisory Committee votes in favour of maintaining accelerated approval of Roche’s Tecentriq for PD-L1-positive, metastatic triple-negative breast cancer

Ads